Diagnostic Technologies (US) sues Dianon Systems for $10 million:
This article was originally published in Clinica
Diagnostic Technologies (US) is suing Dianon Systems (US) for breach of contract, reliance and interference with business advantage. The suit comes after Dianon decided not to enter into an agreement with Diagnostic for the development and licensing of technology relating to an assay for identifying pre-term delivery, pre-eclampsia toxaemia and intra-uterine growth retardation. Dianon chairman Richard Sandberg confirms that the claims, filed in the Central California District Court, seek over $10 million in damages but says they are without merit.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.